KP Tissue Inc. (TSE:KPT – Get Free Report) Director David Spraley sold 3,668 shares of KP Tissue stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of C$13.30, for a total transaction of C$48,784.40. Following the sale, the director owned 15,712 shares of the company’s stock, valued at approximately C$208,969.60. The trade was a 18.93% decrease in their ownership of the stock.
KP Tissue Price Performance
TSE:KPT opened at C$13.17 on Friday. The firm has a market capitalization of C$132.07 million, a P/E ratio of 14.63, a PEG ratio of -0.88 and a beta of 0.55. KP Tissue Inc. has a 1-year low of C$8.73 and a 1-year high of C$13.49. The company’s fifty day moving average price is C$11.86 and its 200-day moving average price is C$11.01.
KP Tissue (TSE:KPT – Get Free Report) last posted its earnings results on Thursday, May 14th. The company reported C$0.22 earnings per share (EPS) for the quarter. Equities analysts anticipate that KP Tissue Inc. will post 0.4398964 EPS for the current fiscal year.
KP Tissue Announces Dividend
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on the company. TD lifted their price target on KP Tissue from C$11.00 to C$12.00 and gave the company a “hold” rating in a research report on Friday, May 15th. Desjardins lifted their target price on shares of KP Tissue from C$12.00 to C$12.50 and gave the company a “hold” rating in a report on Friday, May 15th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of C$11.62.
Check Out Our Latest Analysis on KP Tissue
About KP Tissue
KP Tissue Inc operates as a holding company. The firm produces, distributes, markets, and sells a range of disposable tissue products in North America. It offers bathroom and facial tissues, paper towels, paper towels, and napkins, as well as disposable wiping products and washroom dispensing systems.
Featured Stories
- Five stocks we like better than KP Tissue
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
